Cetera Investment Advisers’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $121M | Buy |
345,260
+2,800
| +0.8% | +$998K | 0.13% | 143 |
|
|
2025
Q4 | $112M | Buy |
342,460
+16,913
| +5% | +$5.36M | 0.12% | 149 |
|
|
2025
Q3 | $91.9M | Buy |
325,547
+102,251
| +46% | +$29.7M | 0.11% | 176 |
|
|
2025
Q2 | $62.3M | Sell |
223,296
-2,923
| -1% | -$828K | 0.11% | 185 |
|
|
2025
Q1 | $70.5M | Buy |
226,219
+26,309
| +13% | +$7.77M | 0.14% | 149 |
|
|
2024
Q4 | $52.1M | Buy |
199,910
+11
| +0% | +$3.26K | 0.11% | 187 |
|
|
2024
Q3 | $64.4M | Sell |
199,899
-2,849
| -1% | -$932K | 0.14% | 146 |
|
|
2024
Q2 | $63.3M | Sell |
202,748
-30,631
| -13% | -$9M | 0.15% | 136 |
|
|
2024
Q1 | $66.4M | Buy |
233,379
+170,108
| +269% | +$49.8M | 0.16% | 126 |
|
|
2023
Q4 | $18.2M | Sell |
63,271
-934
| -1% | -$254K | 0.15% | 133 |
|
|
2023
Q3 | $17.3M | Buy |
64,205
+3,146
| +5% | +$785K | 0.15% | 135 |
|
|
2023
Q2 | $13.6M | Buy |
61,059
+4,862
| +9% | +$1.13M | 0.11% | 160 |
|
|
2023
Q1 | $13.6M | Buy |
56,197
+3,039
| +6% | +$746K | 0.12% | 155 |
|
|
2022
Q4 | $14M | Sell |
53,158
-21,776
| -29% | -$5.84M | 0.13% | 155 |
|
|
2022
Q3 | $17K | Buy |
74,934
+30,228
| +68% | +$7.33M | ﹤0.01% | 1643 |
|
|
2022
Q2 | $10.9M | Buy |
44,706
+2,142
| +5% | +$525K | 0.17% | 121 |
|
|
2022
Q1 | $10.3M | Buy |
42,564
+3,735
| +10% | +$858K | 0.15% | 141 |
|
|
2021
Q4 | $8.73M | Buy |
38,829
+1,602
| +4% | +$338K | 0.13% | 174 |
|
|
2021
Q3 | $7.92M | Sell |
37,227
-2,881
| -7% | -$663K | 0.13% | 182 |
|
|
2021
Q2 | $9.78M | Buy |
40,108
+10,819
| +37% | +$2.66M | 0.16% | 148 |
|
|
2021
Q1 | $7.29M | Sell |
29,289
-6,781
| -19% | -$1.62M | 0.14% | 153 |
|
|
2020
Q4 | $8.29M | Buy |
36,070
+33,811
| +1,497% | +$7.8M | 0.16% | 139 |
|
|
2020
Q3 | $574K | Sell |
2,259
-39
| -2% | -$9.66K | 0.05% | 349 |
|
|
2020
Q2 | $542K | Sell |
2,298
-46
| -2% | -$10.5K | 0.05% | 339 |
|
|
2020
Q1 | $475K | Sell |
2,344
-32
| -1% | -$6.99K | 0.06% | 312 |
|
|
2019
Q4 | $572K | Buy |
2,376
+438
| +23% | +$96.5K | 0.06% | 315 |
|
|
2019
Q3 | $378K | Buy |
1,938
+305
| +19% | +$58.5K | 0.05% | 358 |
|
|
2019
Q2 | $302K | Buy |
1,633
+154
| +10% | +$27.6K | 0.04% | 383 |
|
|
2019
Q1 | $282K | Sell |
1,479
-2,211
| -60% | -$422K | 0.04% | 383 |
|
|
2018
Q4 | $720K | Sell |
3,690
-369
| -9% | -$72K | 0.12% | 190 |
|
|
2018
Q3 | $838K | Buy |
4,059
+1,381
| +52% | +$272K | 0.12% | 187 |
|
|
2018
Q2 | $493K | Sell |
2,678
-150
| -5% | -$26.5K | 0.09% | 243 |
|
|
2018
Q1 | $482K | Sell |
2,828
-849
| -23% | -$156K | 0.09% | 232 |
|
|
2017
Q4 | $637K | Buy |
3,677
+213
| +6% | +$37.7K | 0.12% | 206 |
|
|
2017
Q3 | $650K | Buy |
3,464
+386
| +13% | +$68.4K | 0.14% | 188 |
|
|
2017
Q2 | $529K | Buy |
3,078
+511
| +20% | +$83.1K | 0.13% | 206 |
|
|
2017
Q1 | $423K | Buy |
2,567
+172
| +7% | +$28.6K | 0.12% | 224 |
|
|
2016
Q4 | $349K | Buy |
2,395
+874
| +57% | +$132K | 0.12% | 223 |
|
|
2016
Q3 | $254K | Sell |
1,521
-3,479
| -70% | -$588K | 0.11% | 217 |
|
|
2016
Q2 | $759K | Buy |
5,000
+366
| +8% | +$56.9K | 0.3% | 106 |
|
|
2016
Q1 | $694K | Buy |
4,634
+156
| +3% | +$23.2K | 0.3% | 100 |
|
|
2015
Q4 | $724K | Buy |
+4,478
| New | +$704K | 0.33% | 91 |
|
Other funds holding AMGN
VCM
VPM
Cetera Investment Advisers's AMGN Position: Q1 2026 in Review
Cetera Investment Advisers increased its Amgen (AMGN) stake by 0.82% in Q1 2026, buying an estimated $998K and bringing the position to 345,260 shares worth $121M. The position accounts for 0.13% of the portfolio, ranked #143.
Cetera Investment Advisers first reported a position in AMGN in Q4 2015 and has held it in 42 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Cetera Investment Advisers held 345,260 shares of Amgen worth $121M as of Q1 2026.
- Cetera Investment Advisers bought 2,800 Amgen shares in Q1 2026, an estimated $998K.
- Amgen made up 0.13% of Cetera Investment Advisers's portfolio in Q1 2026, its #143 holding.
- Cetera Investment Advisers first reported a position in Amgen in Q4 2015 and has held it in 42 quarters since.
- 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.